The number of times the tube is dislodged for every 10 days of feeding tubes.
| Group | Value | 95% CI |
|---|---|---|
| Nasal Bridle to Secure Feeding Tube | 0.16 | 0 – 10 |
| Adhesive Tape Use to Secure Feeding Tube | 2.11 | 0 – 10 |
Last reviewed · How we verify
Retention of Nasoenteric Feeding Tubes in Pediatric Patients Using a Nasal Bridle
NA trial testing AMT BridlePro Device in Feeding Tube Complication in 35 participants. Completed in 16 September 2021.
| Lead sponsor | The University of Texas Health Science Center at San Antonio |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 35 |
| Start date | 18 February 2020 |
| Primary completion | 30 April 2021 |
| Estimated completion | 16 September 2021 |
| Sites | 1 location across United States |
The University of Texas Health Science Center at San Antonio
Under 18, any sex, with Feeding Tube Complication. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The number of times the tube is dislodged for every 10 days of feeding tubes.
| Group | Value | 95% CI |
|---|---|---|
| Nasal Bridle to Secure Feeding Tube | 0.16 | 0 – 10 |
| Adhesive Tape Use to Secure Feeding Tube | 2.11 | 0 – 10 |
Time frame: 30 days. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.
| Reaction | System | Nasal Bridle to Secure Fee… | Adhesive Tape Use to Secur… |
|---|---|---|---|
| Skin Breakdown | Skin and subcutaneous tissue disorders | — | — |
Data from ClinicalTrials.gov NCT04621734 adverse events section.
A study to compare tube dislodgment rates when a nasoenteric feeding tube is secured with adhesive tape vs the AMT BridlePro device.
1 peer-reviewed publication reference this trial (live from Europe PMC):
Verify or expand the search:
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04621734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing